Vaccine technologies have been in development since the initial use of killed viral and killed bacterial vaccines.
LPI (LP Information)' newest research report, the “Vaccine Technologies Industry Forecast” looks at past sales and reviews total world Vaccine Technologies sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Technologies sales for 2023 through 2029. With Vaccine Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Technologies industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Technologies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Technologies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Technologies.
The global Vaccine Technologies market size is projected to grow from US$ 44580 million in 2022 to US$ 65790 million in 2029; it is expected to grow at a CAGR of 5.7% from 2023 to 2029.
United States market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Technologies players cover Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Technologies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Infection
Allergy
Cancer
Segmentation by application
Humans
Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Pfizer
Bayer
GE Healthcare
Glaxosmithkline
Johnson and Johnson
Thermo Fisher Scientific
LPI (LP Information)' newest research report, the “Vaccine Technologies Industry Forecast” looks at past sales and reviews total world Vaccine Technologies sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Technologies sales for 2023 through 2029. With Vaccine Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Technologies industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Technologies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Technologies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Technologies.
The global Vaccine Technologies market size is projected to grow from US$ 44580 million in 2022 to US$ 65790 million in 2029; it is expected to grow at a CAGR of 5.7% from 2023 to 2029.
United States market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Technologies players cover Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Technologies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Infection
Allergy
Cancer
Segmentation by application
Humans
Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Pfizer
Bayer
GE Healthcare
Glaxosmithkline
Johnson and Johnson
Thermo Fisher Scientific
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Technologies Market Size 2018-2029
2.1.2 Vaccine Technologies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vaccine Technologies Segment by Type
2.2.1 Infection
2.2.2 Allergy
2.2.3 Cancer
2.3 Vaccine Technologies Market Size by Type
2.3.1 Vaccine Technologies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vaccine Technologies Market Size Market Share by Type (2018-2023)
2.4 Vaccine Technologies Segment by Application
2.4.1 Humans
2.4.2 Animals
2.5 Vaccine Technologies Market Size by Application
2.5.1 Vaccine Technologies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vaccine Technologies Market Size Market Share by Application (2018-2023)
3 Vaccine Technologies Market Size by Player
3.1 Vaccine Technologies Market Size Market Share by Players
3.1.1 Global Vaccine Technologies Revenue by Players (2018-2023)
3.1.2 Global Vaccine Technologies Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccine Technologies by Regions
4.1 Vaccine Technologies Market Size by Regions (2018-2023)
4.2 Americas Vaccine Technologies Market Size Growth (2018-2023)
4.3 APAC Vaccine Technologies Market Size Growth (2018-2023)
4.4 Europe Vaccine Technologies Market Size Growth (2018-2023)
4.5 Middle East & Africa Vaccine Technologies Market Size Growth (2018-2023)
5 Americas
5.1 Americas Vaccine Technologies Market Size by Country (2018-2023)
5.2 Americas Vaccine Technologies Market Size by Type (2018-2023)
5.3 Americas Vaccine Technologies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Technologies Market Size by Region (2018-2023)
6.2 APAC Vaccine Technologies Market Size by Type (2018-2023)
6.3 APAC Vaccine Technologies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine Technologies by Country (2018-2023)
7.2 Europe Vaccine Technologies Market Size by Type (2018-2023)
7.3 Europe Vaccine Technologies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Technologies by Region (2018-2023)
8.2 Middle East & Africa Vaccine Technologies Market Size by Type (2018-2023)
8.3 Middle East & Africa Vaccine Technologies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccine Technologies Market Forecast
10.1 Global Vaccine Technologies Forecast by Regions (2024-2029)
10.1.1 Global Vaccine Technologies Forecast by Regions (2024-2029)
10.1.2 Americas Vaccine Technologies Forecast
10.1.3 APAC Vaccine Technologies Forecast
10.1.4 Europe Vaccine Technologies Forecast
10.1.5 Middle East & Africa Vaccine Technologies Forecast
10.2 Americas Vaccine Technologies Forecast by Country (2024-2029)
10.2.1 United States Vaccine Technologies Market Forecast
10.2.2 Canada Vaccine Technologies Market Forecast
10.2.3 Mexico Vaccine Technologies Market Forecast
10.2.4 Brazil Vaccine Technologies Market Forecast
10.3 APAC Vaccine Technologies Forecast by Region (2024-2029)
10.3.1 China Vaccine Technologies Market Forecast
10.3.2 Japan Vaccine Technologies Market Forecast
10.3.3 Korea Vaccine Technologies Market Forecast
10.3.4 Southeast Asia Vaccine Technologies Market Forecast
10.3.5 India Vaccine Technologies Market Forecast
10.3.6 Australia Vaccine Technologies Market Forecast
10.4 Europe Vaccine Technologies Forecast by Country (2024-2029)
10.4.1 Germany Vaccine Technologies Market Forecast
10.4.2 France Vaccine Technologies Market Forecast
10.4.3 UK Vaccine Technologies Market Forecast
10.4.4 Italy Vaccine Technologies Market Forecast
10.4.5 Russia Vaccine Technologies Market Forecast
10.5 Middle East & Africa Vaccine Technologies Forecast by Region (2024-2029)
10.5.1 Egypt Vaccine Technologies Market Forecast
10.5.2 South Africa Vaccine Technologies Market Forecast
10.5.3 Israel Vaccine Technologies Market Forecast
10.5.4 Turkey Vaccine Technologies Market Forecast
10.5.5 GCC Countries Vaccine Technologies Market Forecast
10.6 Global Vaccine Technologies Forecast by Type (2024-2029)
10.7 Global Vaccine Technologies Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Vaccine Technologies Product Offered
11.1.3 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Vaccine Technologies Product Offered
11.2.3 Pfizer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Vaccine Technologies Product Offered
11.3.3 Bayer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Information
11.4.2 GE Healthcare Vaccine Technologies Product Offered
11.4.3 GE Healthcare Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GE Healthcare Main Business Overview
11.4.5 GE Healthcare Latest Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Information
11.5.2 Glaxosmithkline Vaccine Technologies Product Offered
11.5.3 Glaxosmithkline Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Glaxosmithkline Main Business Overview
11.5.5 Glaxosmithkline Latest Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Information
11.6.2 Johnson and Johnson Vaccine Technologies Product Offered
11.6.3 Johnson and Johnson Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Johnson and Johnson Main Business Overview
11.6.5 Johnson and Johnson Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Vaccine Technologies Product Offered
11.7.3 Thermo Fisher Scientific Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Technologies Market Size 2018-2029
2.1.2 Vaccine Technologies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vaccine Technologies Segment by Type
2.2.1 Infection
2.2.2 Allergy
2.2.3 Cancer
2.3 Vaccine Technologies Market Size by Type
2.3.1 Vaccine Technologies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vaccine Technologies Market Size Market Share by Type (2018-2023)
2.4 Vaccine Technologies Segment by Application
2.4.1 Humans
2.4.2 Animals
2.5 Vaccine Technologies Market Size by Application
2.5.1 Vaccine Technologies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vaccine Technologies Market Size Market Share by Application (2018-2023)
3 Vaccine Technologies Market Size by Player
3.1 Vaccine Technologies Market Size Market Share by Players
3.1.1 Global Vaccine Technologies Revenue by Players (2018-2023)
3.1.2 Global Vaccine Technologies Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccine Technologies by Regions
4.1 Vaccine Technologies Market Size by Regions (2018-2023)
4.2 Americas Vaccine Technologies Market Size Growth (2018-2023)
4.3 APAC Vaccine Technologies Market Size Growth (2018-2023)
4.4 Europe Vaccine Technologies Market Size Growth (2018-2023)
4.5 Middle East & Africa Vaccine Technologies Market Size Growth (2018-2023)
5 Americas
5.1 Americas Vaccine Technologies Market Size by Country (2018-2023)
5.2 Americas Vaccine Technologies Market Size by Type (2018-2023)
5.3 Americas Vaccine Technologies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Technologies Market Size by Region (2018-2023)
6.2 APAC Vaccine Technologies Market Size by Type (2018-2023)
6.3 APAC Vaccine Technologies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine Technologies by Country (2018-2023)
7.2 Europe Vaccine Technologies Market Size by Type (2018-2023)
7.3 Europe Vaccine Technologies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Technologies by Region (2018-2023)
8.2 Middle East & Africa Vaccine Technologies Market Size by Type (2018-2023)
8.3 Middle East & Africa Vaccine Technologies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccine Technologies Market Forecast
10.1 Global Vaccine Technologies Forecast by Regions (2024-2029)
10.1.1 Global Vaccine Technologies Forecast by Regions (2024-2029)
10.1.2 Americas Vaccine Technologies Forecast
10.1.3 APAC Vaccine Technologies Forecast
10.1.4 Europe Vaccine Technologies Forecast
10.1.5 Middle East & Africa Vaccine Technologies Forecast
10.2 Americas Vaccine Technologies Forecast by Country (2024-2029)
10.2.1 United States Vaccine Technologies Market Forecast
10.2.2 Canada Vaccine Technologies Market Forecast
10.2.3 Mexico Vaccine Technologies Market Forecast
10.2.4 Brazil Vaccine Technologies Market Forecast
10.3 APAC Vaccine Technologies Forecast by Region (2024-2029)
10.3.1 China Vaccine Technologies Market Forecast
10.3.2 Japan Vaccine Technologies Market Forecast
10.3.3 Korea Vaccine Technologies Market Forecast
10.3.4 Southeast Asia Vaccine Technologies Market Forecast
10.3.5 India Vaccine Technologies Market Forecast
10.3.6 Australia Vaccine Technologies Market Forecast
10.4 Europe Vaccine Technologies Forecast by Country (2024-2029)
10.4.1 Germany Vaccine Technologies Market Forecast
10.4.2 France Vaccine Technologies Market Forecast
10.4.3 UK Vaccine Technologies Market Forecast
10.4.4 Italy Vaccine Technologies Market Forecast
10.4.5 Russia Vaccine Technologies Market Forecast
10.5 Middle East & Africa Vaccine Technologies Forecast by Region (2024-2029)
10.5.1 Egypt Vaccine Technologies Market Forecast
10.5.2 South Africa Vaccine Technologies Market Forecast
10.5.3 Israel Vaccine Technologies Market Forecast
10.5.4 Turkey Vaccine Technologies Market Forecast
10.5.5 GCC Countries Vaccine Technologies Market Forecast
10.6 Global Vaccine Technologies Forecast by Type (2024-2029)
10.7 Global Vaccine Technologies Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Vaccine Technologies Product Offered
11.1.3 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Vaccine Technologies Product Offered
11.2.3 Pfizer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Vaccine Technologies Product Offered
11.3.3 Bayer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Information
11.4.2 GE Healthcare Vaccine Technologies Product Offered
11.4.3 GE Healthcare Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GE Healthcare Main Business Overview
11.4.5 GE Healthcare Latest Developments
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Information
11.5.2 Glaxosmithkline Vaccine Technologies Product Offered
11.5.3 Glaxosmithkline Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Glaxosmithkline Main Business Overview
11.5.5 Glaxosmithkline Latest Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Information
11.6.2 Johnson and Johnson Vaccine Technologies Product Offered
11.6.3 Johnson and Johnson Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Johnson and Johnson Main Business Overview
11.6.5 Johnson and Johnson Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Vaccine Technologies Product Offered
11.7.3 Thermo Fisher Scientific Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.